Inmode Ltd
NASDAQ:INMD
Operating Margin
Inmode Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IL |
|
Inmode Ltd
NASDAQ:INMD
|
1.1B USD |
29%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
215.5B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
132.2B USD |
18%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.9B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.4B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
60.4B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.9B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
41.3B USD |
27%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.1B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
32.1B USD |
29%
|
Inmode Ltd
Glance View
InMode Ltd., founded in 2008, has emerged as a dynamic player in the field of minimally invasive aesthetic medical treatments. Born during a period where the health and beauty sectors were experiencing rapid technological innovation, the company quickly carved a niche for itself by addressing a clear market need: the rising demand for non-surgical procedures. At its heart, InMode merges the precision of medical technology with the principles of aesthetic enhancement. Its primary offerings revolve around radio-frequency-based devices that healthcare providers use to achieve results that traditionally required more invasive techniques. This includes skin tightening, fat reduction, and body contouring solutions, all tailored to meet the growing consumer appetite for treatments that carry less downtime and risk compared to conventional surgery. The company monetizes its expertise by manufacturing and selling these state-of-the-art devices to a diverse group of users, ranging from dermatologists and plastic surgeons to aesthetic practices. InMode's revenue streams are bolstered by not only the direct sale of these devices but also by ongoing client relationships through service agreements and consumable products that are essential for their machine operation. It is a model that ensures continuous engagement with their clients, providing both stability and growth in revenue. By focusing on innovation and efficacy, InMode has successfully captured a significant share of the aesthetic medical market, embodying a business strategy that combines cutting-edge technology with practical solutions to consumer needs.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Inmode Ltd's most recent financial statements, the company has Operating Margin of 28.5%.
You don't have any saved screeners yet